Results 231 to 240 of about 62,912 (312)

Tofacitinib extends survival in a mouse model of ALS through NK cell-independent mechanisms. [PDF]

open access: yesFront Immunol
Baird LA   +10 more
europepmc   +1 more source

JAK inhibitors in the management of extra-intestinal manifestations in inflammatory bowel disease. [PDF]

open access: yesTherap Adv Gastroenterol
Fousekis FS   +4 more
europepmc   +1 more source

FDA-approved small-molecule kinase inhibitors [PDF]

open access: yes, 2015
Clausen, Mads Hartvig   +2 more
core   +1 more source

SAT0252 Clinical and functional response to tofacitinib and adalimumab in patients with rheumatoid arthritis: probability plot analysis of results from the oral strategy trial [PDF]

open access: bronze, 2018
Tsutomu Takeuchi   +7 more
openalex   +1 more source

796 – Real-World Effectiveness of Tofacitinib in Ulcerative Colitis; a Multi-Center Study

open access: bronze, 2019
Anish Patel   +17 more
openalex   +1 more source

Home - About - Disclaimer - Privacy